South Korea Cellular Health Screening Market Size & Outlook

The cellular health screening market in South Korea is expected to reach a projected revenue of US$ 139.0 million by 2033. A compound annual growth rate of 10.9% is expected of South Korea cellular health screening market from 2025 to 2033.
Revenue, 2024 (US$M)
$55.1
Forecast, 2033 (US$M)
$139.0
CAGR, 2025 - 2033
10.9%
Report Coverage
South Korea

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Korea cellular health screening market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Korea cellular health screening market highlights

  • The South Korea cellular health screening market generated a revenue of USD 55.1 million in 2024 and is expected to reach USD 139.0 million by 2033.
  • The South Korea market is expected to grow at a CAGR of 10.9% from 2025 to 2033.
  • In terms of segment, single test panels was the largest revenue generating test type in 2024.
  • Multi-test Panels is the most lucrative test type segment registering the fastest growth during the forecast period.


Cellular health screening market data book summary

Market revenue in 2024USD 55.1 million
Market revenue in 2033USD 139.0 million
Growth rate10.9% (CAGR from 2025 to 2033)
Largest segmentSingle test panels
Fastest growing segmentMulti-test Panels
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationSingle Test Panels, Multi-test Panels
Key market players worldwideCytek Biosciences Inc, Quest Diagnostics Inc, Labcorp Holdings Inc, OPKO Health Inc, Applied DNA Sciences Inc


Other key industry trends

  • In terms of revenue, South Korea accounted for 1.7% of the global cellular health screening market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, China cellular health screening market is projected to lead the regional market in terms of revenue in 2033.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 295.2 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cellular Health Screening Market Scope

Cellular health screening market segmentation & scope
Telomere Tests
Oxidative Stress Tests
Inflammation Tests
Heavy Metals Tests
Multi-test Panels
Blood
Saliva
Serum
Urine
Home
Offices
Hospitals
Diagnostic Labs

Cellular Health Screening Market Companies

Name Profile # Employees HQ Website
Cytek Biosciences Inc View profile 637 47215 Lakeview Boulevard, Fremont, CA, United States, 94538 https://www.cytekbio.com
OPKO Health Inc View profile 3930 4400 Biscayne Boulevard, Miami, FL, United States, 33137 https://www.opko.com
Applied DNA Sciences Inc View profile 55 50 Health Sciences Drive, Stony Brook, New York, NY, United States, 11790 https://www.adnas.com
Labcorp Holdings Inc View profile 67000 358 South Main Street, Burlington, NC, United States, 27215 https://www.labcorp.com
Quest Diagnostics Inc View profile 48000 500 Plaza Drive, Secaucus, NJ, United States, 07094 https://www.questdiagnostics.com

South Korea cellular health screening market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cellular health screening market will help companies and investors design strategic landscapes.


Single test panels was the largest segment with a revenue share of 85.84% in 2024. Horizon Databook has segmented the South Korea cellular health screening market based on single test panels, multi-test panels covering the revenue growth of each sub-segment from 2021 to 2033.


Chronic diseases, such as heart disease and cancer, caused more than 80% of mortality in South Korea. According to a report published by Korea Center for Disease Control and Prevention, chronic diseases accounted for seven of the top 10 causes of death in 2013. 

Cancer, circulatory system diseases, lower respiratory diseases, and diabetes accounted for 70% of all deaths in 2013. Health risk behavior including lack of physical activity, excessive drinking, and smoking along with unhealthy diet is a major cause of severe chronic conditions. 

Chronic conditions such as arthritis, prediabetes, and obesity are among the most prevalent and preventable of all health conditions. 

Reasons to subscribe to South Korea cellular health screening market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea cellular health screening market databook

  • Our clientele includes a mix of cellular health screening market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea cellular health screening market , including forecasts for subscribers. This country databook contains high-level insights into South Korea cellular health screening market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea cellular health screening market size, by test type, 2021-2033 (US$M)

South Korea Cellular Health Screening Market Outlook Share, 2024 & 2033 (US$M)

South Korea cellular health screening market size, by test type, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online